These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
26. Botox for the brain: enhancement of cognition, mood and pro-social behavior and blunting of unwanted memories. de Jongh R; Bolt I; Schermer M; Olivier B Neurosci Biobehav Rev; 2008; 32(4):760-76. PubMed ID: 18295885 [TBL] [Abstract][Full Text] [Related]
27. Reasons for prescribing cognition enhancers in primary care. Results of a representative survey in Lower Saxony, Germany. Stoppe G; Sandholzer H; Staedt J; Winter S; Kiefer J; Rüther E Int J Clin Pharmacol Ther; 1995 Sep; 33(9):486-90. PubMed ID: 8520805 [TBL] [Abstract][Full Text] [Related]
28. Estrogen and cognition, with a focus on Alzheimer's disease. Pinkerton JV; Henderson VW Semin Reprod Med; 2005 May; 23(2):172-9. PubMed ID: 15852203 [TBL] [Abstract][Full Text] [Related]
29. Problems in the search for cognition enhancers. Hollister LE Pharmacopsychiatry; 1990 Feb; 23 Suppl 2():33-6. PubMed ID: 2186410 [TBL] [Abstract][Full Text] [Related]
30. [Neurotransmitters in Alzheimer's disease]. Kristensen MO Ugeskr Laeger; 1990 Jul; 152(30):2165-8. PubMed ID: 1975961 [TBL] [Abstract][Full Text] [Related]
31. Methylphenidate preferentially increases catecholamine neurotransmission within the prefrontal cortex at low doses that enhance cognitive function. Berridge CW; Devilbiss DM; Andrzejewski ME; Arnsten AF; Kelley AE; Schmeichel B; Hamilton C; Spencer RC Biol Psychiatry; 2006 Nov; 60(10):1111-20. PubMed ID: 16806100 [TBL] [Abstract][Full Text] [Related]
32. Targeting the CREB pathway for memory enhancers. Tully T; Bourtchouladze R; Scott R; Tallman J Nat Rev Drug Discov; 2003 Apr; 2(4):267-77. PubMed ID: 12669026 [TBL] [Abstract][Full Text] [Related]
33. How do neuropeptides alter cognitive performance? Sahgal A Pol J Pharmacol Pharm; 1990; 42(6):527-35. PubMed ID: 2103004 [TBL] [Abstract][Full Text] [Related]
34. Memory, thinking, and aging. What we know about what we know. Teri L; McCurry SM; Logsdon RG West J Med; 1997 Oct; 167(4):269-75. PubMed ID: 9348759 [TBL] [Abstract][Full Text] [Related]
35. Pharmacological actions of Thespesia populnea relevant to Alzheimer's disease. Vasudevan M; Parle M Phytomedicine; 2006 Nov; 13(9-10):677-87. PubMed ID: 16860552 [TBL] [Abstract][Full Text] [Related]
36. Cognitive enhancing agents: current status in the treatment of Alzheimer's disease. Waters C Can J Neurol Sci; 1988 Aug; 15(3):249-56. PubMed ID: 3061625 [TBL] [Abstract][Full Text] [Related]
37. An hypothesis on the role of glucose in the mechanism of action of cognitive enhancers. Wenk GL Psychopharmacology (Berl); 1989; 99(4):431-8. PubMed ID: 2687922 [TBL] [Abstract][Full Text] [Related]